EUVIMEDEUVIMED entdecken
Crossref

Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients

Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Froment Tilikete, Françoise Borson-Chazot, Romain Manet, Juliette Abeillon Du Payrat

Annales d'Endocrinologie · 2023

DOI: 10.1016/j.ando.2023.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales d'Endocrinologie, 2023. Verfasst von Victor Vermot-Desroches und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuro-Ophthalmology, Hôpital Pierre-Wertheimer, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: victor.vermot-desroche…. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Optic Nerve Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To identify initial features associated with significant recovery in patients with Graves' disease dysthyroid optic neuropathy (DON) treated according to EUGOGO guidelines by intravenous glucocorticoids (ivGC) and decompression surgery in first and second-line, respectively. PATIENTS AND METHODS: Consecutive patients referred to our expert multidisciplinary consultation over a 6-year period underwent systematic exploration: endocrine assessment, ophthalmic examination and radiological exploration. Visual recovery, based on best-corrected visual acuity (BCVA) and visual field (VF), were evaluated at baseline, 1week and 6months. Baseline parameters were then tested for prognostic value on univariate and multivariate analyses. RESULTS: Thirty-eight patients (69 eyes) with DON were included. Significant recovery at 6months was found in 48/69 eyes (70%), partial recovery in 18/69 (26%), and no recovery in 3/69 (4%). Fifty-one eyes (28 patients) required surgical decompression after ivGC. These patients showed more severe presentation at diagnosis, had received significantly less GC for Graves' orbitopathy before onset of DON, and showed greater fat prolapse on CT scans compared to non-operated patients. On multivariate analysis, male gender (P=0.001), cumulative GC dose>1g before DON diagnosis (P=0.048) and initial BCVA≤0.3 (P=0.004) were significantly associated with better outcomes, whereas Clinical Activity Score>5 (P=0.013) was associated with a poorer outcome. CONCLUSION: This study confirms a generally favorable 6-month recovery rate in DON treated according to EUGOGO guidelines and provides new information on baseline predictors of poor evolution. These results may help the respective indications for medical and surgical treatment to be more effectively combined in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyOptic Nerve DiseasesHumansMalePrognosisVisual AcuityDecompression, SurgicalGlucocorticoidsRetrospective Studies

Stichwörter der Autor:innen

Dysthyroid optic neuropathyGraves’ orbitopathyOrbital decompressionThyroid eye disease

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Neuro-Ophthalmology, Hôpital Pierre-Wertheimer, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: victor.vermot-desroches@chu-lyon.fr.
  • Department of Neuro-Ophthalmology, Hôpital Pierre-Wertheimer, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: kim.thia@chu-lyon.fr.
  • Department of Endocrinology, Hôpital Louis-Pradel, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: perrine.raymond@hotmail.fr.
  • Department of Radiology, Hôpital Pierre-Wertheimer, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: andrea.filip@chu-lyon.fr.
  • Department of Endocrinology, Hôpital Louis-Pradel, Hospices Civils de Lyon, 69500 Bron, France; Claude-Bernard Lyon I University, Bron, France. Electronic address: jacques.orgiazzi@orange.fr.
  • Claude-Bernard Lyon I University, Bron, France; Department of Neurosurgery B, Hôpital Pierre-Wertheimer, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: emmanuel.jouanneau@chu-lyon.fr.

Zitieren

APA

Vermot-Desroches, V., Thia-Soui-Tchong, K., Raymond, P., Filip, A., Orgiazzi, J., Jouanneau, E., Froment Tilikete, C., Borson-Chazot, F., Manet, R., & Abeillon Du Payrat, J. (2023). Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients. Annales d'Endocrinologie. https://doi.org/10.1016/j.ando.2023.04.002

Vancouver

Vermot-Desroches V, Thia-Soui-Tchong K, Raymond P, Filip A, Orgiazzi J, Jouanneau E, et al. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients. Annales d'Endocrinologie. 2023. doi:10.1016/j.ando.2023.04.002

BibTeX
@article{VermotDesroches2023,
  author = {Vermot-Desroches, Victor and Thia-Soui-Tchong, Kim and Raymond, Perrine and Filip, Andrea and Orgiazzi, Jacques and Jouanneau, Emmanuel and Froment Tilikete, Caroline and Borson-Chazot, Françoise and Manet, Romain and Abeillon Du Payrat, Juliette},
  title = {Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients},
  journal = {Annales d'Endocrinologie},
  year = {2023},
  doi = {10.1016/j.ando.2023.04.002}
}
Kostenlos starten →